primenewsnow
5+ Views
primenewsnow
0 Likes
0 Shares
Comment
Suggested
Recent
Cards you may also be interested in
Cancer Diagnostics Market - Global Key Players, Trends, Industry Size & Forecast
Growth Factors Driving the Market:  The Growth of the Cancer Diagnostics Market is driven mainly by increasing incidence of cancer and growth in the number of private diagnostic laboratories. In an attempt to detect cancer in the early stages and bring down the mortality rate, governments in developed countries and primary care doctors are recommending cancer screening tests for patients. The US Preventive Services Task Force (USPSTF) recommends screening for colorectal cancer starting at 50 years of age to 75 years of age in the US as a means of preventing disease incidence and ensuring early-stage treatment. Canada has also implemented guidelines for biennial colorectal cancer screening for people aged 50 to 74 years. MarketsandMarkets™ View on Revenue: The global cancer diagnostics market size was valued at USD 17.2 billion in 2021 and is expected to grow at a CAGR of 11.5% Industry Segmentation in Detailed: The consumables segment is expected to grow at the highest CAGR during the forecast period. Based on the product, the cancer diagnostics market is segmented into consumables and instruments. The consumables segment is projected to witness the highest growth during the forecast period. The repeated purchase and high consumption, and the high prevalence of diseases the major factors supporting the growth of this segment. The technology segment accounted for the largest share of the cancer diagnostics market. By technology, the cancer diagnostics market is segmented IVD testing, imaging based and biopsy technique. The IVD testing segment accounted for the largest market share in 2020. The large share of this segment can be attributed to increasing incidence of cancer. Hospitals for the largest share of the cancer diagnostics market. Based on end-users, the cancer diagnostics market is segmented into hospitals and diagnostic laboratories. The hospitals segment accounted for the largest share of the cancer diagnostics market in 2020. The increasing number of patients visiting hospitals, rising number of in-house diagnostic procedures performed in hospitals, and growing awareness regarding early diagnosis is are the major driving factor for this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186559121 Leading Key Players Analysis: Some of the major players operating in this market are GE Healthcare (US), Roche Diagnostics (Switzerland), and Becton, Dickinson and Company (US). In 2020, GE Healthcare held the leading position in the market. The company has a strong geographic presence across the US, Asia, Europe, Middle East and Africa, & the Americas. Moreover, the company’s strong brand recognition and comprehensive product portfolio in the cancer diagnostics market is its key strength. BD held the second position in the cancer diagnostics market in 2020. Geographical Trends in Detailed: The cancer diagnostics market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2020, North America accounted for the largest share of the cancer diagnostics market. The large share of North America can be attributed to factors such as the increasing incidences of cancer, growing awareness early diagnosis and technological advancement. Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=186559121
Orthodontic Supplies Market: Revenue Growth Development and Analysis of Demand
According to the new market research report “Orthodontic Supplies Market by Product (Braces (Removable, Fixed), Brackets (Ligating, Lingual, Metal), Archwires (Ni-Ti, steel), Anchorage, Ligature(Elastomeric, wire), Patient(Adult, Children), Users(Hospitals, Clinics, OTC) – Global Forecast to 2026″, published by MarketsandMarkets™, the Orthodontic Products Market is projected to reach USD 8.3 billion by 2026 from USD 5.4 billion in 2021, at a CAGR of 9.1% during the forecast period. Opportunity: Emerging markets in APAC and RoW; Emerging markets such as China, India, Brazil, and Mexico are expected to offer significant growth opportunities for players in the orthodontic supplies market. Growth in these markets can be attributed to the presence of a large patient population, rising disposable incomes among the middle-class population, and the increasing focus of public and private organizations on increasing the awareness about orthodontic treatments and dental hygiene. To leverage the significant growth opportunities in emerging countries, players are increasingly focusing on undertaking strategic developments to increase their presence in these markets and tap a large number of customers. Along with this, many players are focusing on strategic investments to develop end-to-end digital software solutions with 3D digital scanning, diagnostics, outcome visualization, treatment planning, custom appliances, and custom lab products. For instance, in September 2020, Light Force Orthodontics, a manufacturer of customizable 3D-printed bracket systems, raised USD 14 million from Series B round led by Tyche Partners with follow-on investment from Matrix Partners and AM Ventures. This 3D printing technology helps to create customized braces for each patient. This plays a critical role in significantly reducing the number of visits to orthodontic clinics for the adjustment of braces. These developments are expected to provide a wide range of opportunities for players to capture a large customer base in the orthopedic supplies market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=236529189 The Increasing prevalence of malocclusion, rising emphasis on effective orthodontic treatment and t the initiatives undertaken by governments to increase the awareness about orthodontic treatments are fueling the demand for orthodontic supplies during the forecast period. The orthodontic supplies market includes major Tier I and II suppliers of orthodontic products are 3M (US), Envista Holdings Corporation (US), Dentsply Sirona (US), Align Technology (US), American Orthodontics (US), Rocky Mountain Orthodontics (US), G&H Orthodontics (US), Dentaurum (Germany), TP Orthodontics (US), Great Lakes Dental Technologies (US), DB Orthodontics (UK), Morelli Orthodontics (Brazil), ClearCorrect (US), and Ultradent Products (US). These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. Due to the pandemic, the orthodontic supplies market experienced short-term negative growth, which can be attributed to a sharp reduction in access to hospital and dental clinics and the temporarily shutdown of orthodontic clinics. Orthodontic practices around the globe are facing challenges amid the pandemic. The adoption of strict protocols outside and inside dental clinics, increasing usage of teleorthodontics in case of urgent appointments, and opting for minimal orthodontic treatment procedures by many orthodontic clinics are likely to have a positive impact on the market. Moreover, post lockdown, as dental practices reopen, it is expected that patient volumes are anticipated to rebound at a higher pace. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=236529189 Demand for invisible braces among the target population due to their aesthetic benefits drives the growth of removable braces Removable braces offer advantages over traditional braces, including easy removal of braces, reduced risk of periodontal diseases & tooth decay, and enhanced comfort. Factors such as strong focus on product innovation by players and growing awareness about the benefits associated with removable braces and the growing demand for invisible braces among teens and adults due to their aesthetic benefits is augumenting the growth of removable braces. Asia Pacific likely to emerge as the fastest growing orthodontic supplies market, globally Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 10.8% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, increase patient population with malocclusion and tooth decay are factors likely to support the growth of market in the region. Moreover, the growing focus toward aesthetics products among adults and emergence of small manufacturers in the market are driving the growth of the APAC orthodontic supplies market. Prominent players in this market are 3M (US), Envista Holdings Corporation (US), Dentsply Sirona (US), Align Technology (US), Rocky Mountain Orthodontics (US), G&H Orthodontics (US), Dentaurum (Germany), TP Orthodontics (US), Great Lakes Dental Technologies (US), DB Orthodontics (UK), among others. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=236529189
Artificial Cornea and Corneal Implant Market - Growth and key Players Analysis and Forecast
According to the new market research report “Artificial Cornea Implant Market by Type (Human Cornea, Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty), Disease Indication, End Users (Hospitals, Specialty Clinics & ASCs) – Global Forecast to 2026″, published by MarketsandMarkets™, the global Artificial Cornea Implant Market is projected to reach USD 599 million by 2026 from USD 418 million in 2021, at a CAGR of 7.4% from 2021 to 2026. Opportunity: Shortage of corneal donors; There is a significant requirement of corneal donors across the globe, as approximately 10 million people are in need of corneal transplants. Densely populated counties such as India suffer from a significant shortage of donor corneas, and there is a waiting period of more than six months for corneal transplants among patients suffering from corneal blindness. Approximately 6.8 million people in the country have poor vision in one eye, and nearly one million people have poor vision in both eyes due to corneal disorders. It was estimated that by the end of 2020, India would suffer from 10.6 million cases of unilateral corneal blindness. In 2019, around 120,000 people were affected by corneal blindness. Around 250,000 corneas are needed annually in the country; however, the total number of corneas donated each year is around 25,000. The high burden of corneal blindness, coupled with a shortage of corneal donors, is expected to offer high-growth opportunities to manufacturers of corneal implants. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=182165973 The Corneal Implant Market growth is largely driven by the The growing geriatric population and the rising prevalence of eye diseases are the major drivers for the artificial cornea and corneal implants market. The increasing prevalence of eye disorders and government initiatives to control visual impairment are further boosting the market growth. The artificial cornea segment is projected to witness fastest growth during the forecast period On the basis of type, the artificial cornea and corneal implants market is segmented into human cornea and artificial cornea. The artificial cornea segment is projected to witness fastest growth during the forecast period. An artificial corneal transplant, also known as keratoprosthesis (KPro), enables the restoration of vision in conditions wherein the cornea and the eye surface is affected or damaged. The scarcity of human eye donors has resulted in the development of innovative solutions such as artificial corneas. Additionally, individuals with a history of multiple previous graft failures, Stevens-Johnson syndrome, chemical burns, severe dry eyes, congenital aniridia, or limbal stem cell deficiency are indications for KPro. One of the commonly used keratoprosthesis is Boston Keratoprosthesis (Boston KPro). To date, over 15,000 Boston KPro have been implanted across the globe. Penetrating keratoplasty segment accounted for the largest share of artificial corneal implant market in 2020. On the basis of transplant type, the Artificial Cornea Implant Market is segmented into penetrating keratoplasty, endothelial keratoplasty, and other transplants (including anterior lamellar keratoplasty (ALK) and keratoprosthesis). In 2020, the penetrating keratoplasty segment accounted for the largest share of the global artificial cornea and corneal implants market. The large share of this segment can be attributed to the rising number of people suffering from eye disorders such as infectious keratitis and injury of the eyeball. In 2020, Fuchs’ dystrophy segment accounted for the largest share of artificial cornea market On the basis of disease indication, the corneal implants market is segmented into fungal keratitis, Fuchs’ dystrophy, keratoconus, and other diseases. In 2020, the Fuchs’ dystrophy segment accounted for the largest share of artificial cornea and corneal implant market. The rising incidence of the disease and the growing awareness among people regarding early disease diagnosis are the key factors driving the growth of this segment. In 2020, hospitals segment accounted for the largest share of corneal implant market Based on end users, the artificial cornea and corneal implants market is segmented into hospitals and specialty clinics and ambulatory surgery centers (ASCs). In 2020, hospitals segment accounted for the largest share of artificial corneal implant market. The rising prevalence of eye disorders, growth in the geriatric population, increasing awareness about the innovative artificial corneal technology, the willingness of patients to spend more on advanced treatments, and the growing number of hospitals in developing countries such as India, China, and Brazil are some of the key factors driving the growth of the artificial cornea and corneal implants market for hospitals. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=182165973 Asia Pacific is expected to witness fastest growth during the forecast period of 2021–2026. Geographically, the artificial cornea and corneal implant market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is projected to witness highest CAGR during the forecast period of 2021–2026. The Asia Pacific forms the most lucrative region in the artificial cornea and corneal implants market, owing to the large population in countries such as China and India, rapid growth in the geriatric population, improving healthcare infrastructure, growing per capita income, and the rising focus of key market players on this region. The prominent players in artificial cornea implant market are AJL Ophthalmic (Spain), CorneaGen Inc. (US), Addition Technology, Inc. (US), LinkoCare Life Sciences AB (Sweden), Presbia plc (Ireland), Mediphacos (Brazil), Aurolab (India), Cornea Biosciences (US), DIOPTEX GmbH (Austria), EyeYon Medical (Israel), Massachusetts Eye and Ear (US), Florida Lions Eye Bank (US), SightLife (US), Advancing Sight Network (US), San Diego Eye Bank (US) and L V Prasad Eye Institute (LVPEI, India). peak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=182165973
Ultrasound Market - Developing Regions is Well-Positioned for Strong Growth in the Coming Years
According to the new market research report "Ultrasound Market by Technology (Diagnostic (2D, 3D, Doppler), Therapeutic (HIFU, ESWL)), Display (Color, B&W), Portability (Trolley, POC), Application (Gynecology, Cardiology, Orthopedic), Component (Probe), End user (Hospitals) - Global Forecasts to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 9.0 billion by 2026 from USD 6.7 billion in 2021, at a CAGR of 6.3% during the forecast period. Growth Driver: increasing prevalence of target diseases; The high and increasing incidence of target diseases and conditions will boost the adoption of effective diagnostic and therapeutic procedures. The burden of chronic and lifestyle diseases has increased in recent years. The burden of cancer, for example, was expected to increase from 14.1 million new cases in 2012 to 19.3 million new cases in 2020 (Source: GLOBOCAN, 2020). As ultrasound technologies are cost-effective, safer, and offer earlier diagnosis & treatment of target diseases, their demand in disease management is expected to increase during the forecast period. Important statistics related to other major target diseases have been mentioned below: - According to the American Heart Association, by 2030, about 41.4% of US adults will have hypertension (an increase of 8.4% from 2012) - The burden of cancer, for example, is expected to increase from 14.1 million new cases to 18.1 million new cases during 2012- 2018 (Source: GLOBOCAN, 2018) - Globally, 415 million people had diabetes in 2015; by 2040, this figure will reach 642 million (Source: IDF Diabetes Atlas, 8th Edition). The number of diabetics in developing countries is expected to reach 228 million in 2025. Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=467 The growth of this market is mainly driven by the increasing prevalence of target diseases, which have supported the demand for effective diagnostic procedures. Ultrasound technology has been traditionally used by healthcare professionals in OB/GYN applications for fetal imaging and the diagnosis of fetal abnormalities (such as tangled umbilical cord and developmental abnormalities). With technological advancements in the field of medical imaging as well as minimally invasive surgical procedures, ultrasound is increasingly gaining prominence in disease diagnosis and the treatment for various applications, such as cardiology, vascular disorders, urology, breast cancer, orthopedics, and musculoskeletal injuries. This has led a number of manufacturers and independent researchers to focus on the development and commercialization of application-specific ultrasound devices. The 3D & 4D ultrasound subsegment of diagnostic ultrasound to register significant growth in the ultrasound market by 2026 Based on technology, the market is segmented into diagnostic and therapeutic ultrasound. The diagnostic ultrasound segment is further categorized into 2D, 3D & 4D, and Doppler ultrasound. These technologies are used for the visualization and diagnosis of various medical conditions (such as gynecological disorders and neurological conditions), fetal imaging, and the imaging of organs. The growth of this market is driven by the rising preference for 3D/4D ultrasound across developed markets and their technological benefits as compared to 2D ultrasound. Based on system portability, the trolley/cart-based ultrasound systems segment is expected to account for the largest share of the market in 2020 On the basis of system portability, the ultrasound market is segmented into trolley/cart-based ultrasound systems, compact/handheld ultrasound systems, and point-of-care ultrasound systems. The trolley/cart-based ultrasound systems segment is expected to account for the largest share of the ultrasound market in 2020. The growing demand for trolley/cart-based ultrasound systems is mainly attributed to the growing adoption of these systems across major markets due to their increased use in acute care settings and emergency care in hospitals and healthcare institutions. Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=467 The vascular applications segment is expected to register the highest growth rate during the forecast period Based on application, the market is divided into eight segments-radiology/general imaging applications, obstetrics/gynecology applications, cardiology applications, urological applications, vascular applications, orthopedic & musculoskeletal applications, pain management applications, and other applications. Vascular ultrasound is one of the fastest-growing application segments in the ultrasound market majorly due to the rising incidence of vascular disorders across the globe, coupled with the greater adoption of vascular ultrasound for the diagnosis of these disorders and technological advancements in the field of 3D/4D imaging. On the basis of component, the market is segmented into transducers/probes, workstations, and other components. The transducers/probes segment is further divided into curvilinear/convex array probes, liner array probes, phased array probes, and other probes. The transducers/probes segment accounted for the largest share of the market in 2020. This can be attributed to technological advancements, the introduction of specially designed products, and the rising adoption of ultrasound technology for the diagnosis of various disease indications. Speak to Analyst:https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=467 Europe is expected to dominate the global ultrasound market in 2020 In 2020, Europe is expected to account for the largest share of the global ultrasound market. This can be attributed to the large number of ongoing clinical research projects in the field of ultrasound, expansions in the clinical applications of focused ultrasound (and the early commercialization of these devices in Europe), and the significant healthcare expenditure across mature European countries (such as Germany, France, the UK, Italy, and Spain). GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Hitachi, Ltd. (Japan), Siemens Healthineers AG (Germany), Hologic, Inc. (US), FUJIFILM Holdings Corporation (Japan), Samsung Electronics Co., Ltd. (Korea), Mindray Medical International Limited (China), Analogic Corporation (US), Esaote S.p.A (Italy), Carestream Health (US), CURA Healthcare (India), Chison Medical Technologies Co., Ltd. (China), Mobisante, Inc. (US), Neusoft Corporation (China), Clarius Mobile Health (Canada), Medgyn Products, Inc. (US), and United Imaging Healthcare Co., Ltd. (China), among others are some of the major players operating in the global ultrasound market.
Body Composition Analyzers Market - Growth Factors Analysis, Share and Forecast
According to the new market research report “Body Composition Analyzers Market by Product (Bio-impedance analyzer/DEXA/Skinfold calipers/ADP/Hydrostatic weighing), & End-users (Hospitals/Fitness & wellness centers/Academic & Research Center/Home-users) – Analysis & Global Forecast”, published by MarketsandMarkets™, is poised to reach USD 668.16 Million, growing at a CAGR of 12.7%. The Body composition analysis is the process to evaluate the amount of fat, muscle, and bone in the body. It gives the precise measurement of body fat in relation to lean body mass. Evaluation of body composition is essential in order to determine the risks associated with high or low levels of body fat. The growth of the overall body composition analyzers market can be contributed to rise in obese population across the globe, growing health and fitness consciousness among people, increasing government initiatives to encourage physical activity and technological advancements. In the coming years, the body composition analyzers market is expected to witness the highest growth rate in the Asia-Pacific region. North America is expected to account for the largest share of the global body composition analyzers market. However, inconsistency in the accuracy of different analyzers and high cost of equipment is likely to restrain the growth of the market during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=248209133 Increasing adoption of body composition analyzers to assess the nutritional status in patients is driving the growth of this market; Hospitals; In hospitals, body composition analysis is majorly used for the diagnosis of osteoporosis. For this application, DEXA is utilized to measure bone density for diagnosing osteoporosis and assessing the risk of developing fractures. As a result, the growing prevalence of osteoporosis is expected to increase the adoption of DEXA in various hospitals. Moreover, various hospitals across the globe, such as the Jackson Hospital (U.S.), Ramsay Health Care (U.K.), Apollo Hospitals (India), and Elkhart General Hospital (U.S.), have now included body composition testing as a part of their patient care and wellness programs. Such developments are expected to support the growth of this end-user segment in the coming years Fitness clubs and wellness centers; Over the past few years, the number of fitness clubs has increased significantly as a result of the growing focus on health and fitness among people. At gyms and wellness centers, body composition analyzers not only measure the amount of body fat for weight loss but also provide complete body composition assessment to maintain health. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=248209133 The global body composition analyzers market is segmented on the basis of product type, end users and region. Based on product, the market is segmented into bio-impedance analyzer, dual energy X-ray absorptiometry (DEXA), skin fold Calipers, air displacement plethysmography (ADP) and hydrostatic weighing. The bio-impedance analyzer is expected to account for the largest share of the body composition analyzers market, by product in 2016 and is expected to grow at highest CAGR. This large share can be attributed to the simplicity, low cost, and better accuracy as compared to other body composition analyzers. Based on end users, the market is segmented into hospitals, fitness clubs and wellness centers, academic and research centers. In 2016, hospitals segment is estimated to account for the largest share of the body composition analyzer market, by end users in 2016 and is expected to grow at highest CAGR. The growth of this segment can be attributed to the rise in osteoporosis cases, increasing adoption of body composition analyzers to assess the nutritional status in patients and increasing health consciousness among masses. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=248209133 basis of region, the Body Composition Analyzers Market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the body composition analyzer market. Its large share can be attributed to rising obesity rates and increasing health clubs and fitness centers in the U.S. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period due to rising trend of overweight and obesity in China, and foothold of local players in Japan. The major players in body composition analyzers market include InBody Co., Ltd (South Korea), Tanita Corporation (Japan), Omron Corporation (Japan), Hologic, Inc. (U.S.) and GE Healthcare (U.S.) among others.
Breast Reconstruction Market - Global Industry Leaders & Growth Strategies Adopted
The Research Report on "Breast Reconstruction Market by Product (Breast implant (Silicone, Saline), Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospital, Cosmetology Clinics) - Global Forecast to 2025", is projected to reach USD 603 million by 2025 from USD 430 million in 2020, at a CAGR of 7.0% from 2020 to 2025. The rising incidence of breast cancer and the availability of reimbursement for breast reconstruction are major driving factors for the market. Moreover, the development of 3D-printed breast implants is expected to offer significant growth opportunities to market players in the coming years. Recent Developments in breast reconstruction market; - In 2019, Polytech Health & Aesthetics received US FDA approval for its textured breast implants (macrotextured and polyurethane-coated implants) - In 2018, J&J launched CPX4 breast tissue expander - In 2018, Polytech Health & Aesthetics merged with G&G Biotechnology Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186501593 Industry Segmentation In Detailed: Breast implants accounted for the largest share of the breast reconstruction market. Based on the product, segmented into breast implants, tissue expanders, and acellular dermal matrix. The breast implants segment accounted for the largest market share in 2019. The immediate procedures segment accounted for the largest market share in 2019. Based on the procedure, the breast reconstruction market is segmented into immediate, delayed, and revision procedures. The immediate procedures segment accounted for the largest market share in 2019. This is primarily attributed to the increasing number of surgeries post-mastectomy and rising awareness. The unilateral segment accounted for the largest market share in 2019. Based on type, the breast reconstruction market is segmented into unilateral and bilateral. The unilateral segment accounted for the largest market share in 2019. The increasing incidence of breast cancer and rising awareness are major factors responsible for the dominant share of this segment. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=186501593 Leading Key Players and Analysis: The prominent players operating in the global breast reconstruction market are Johnson & Johnson (US), Allergan (Ireland), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), Polytech Health & Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (Costa Rica), and Silimed (Brazil). Johnson and Johnson (US)is the dominant player in the breast reconstruction market. The company has a strong portfolio of breast reconstruction products. It has established a significant footprint in Europe, Asia, and Latin, South, & North America. It focuses on organic and inorganic strategies such as product launches. The company operates in this market through Mentor, which it acquired in January 2009. J&J has a strong presence in over 60 countries and a wide network of subsidiaries across the globe. It recently launched a new warranty program for all MENTOR breast implants sold in the US. Allergan (Ireland)is one of the leading players in the breast reconstruction market. The company sells its products in more than 100 countries and has a significant global footprint owing to its strong sales and distribution network. The company is likely to maintain its leading position in this market, owing to its robust portfolio of breast reconstruction products and incessant efforts to develop innovative products by investing in R&D. In order to sustain its leading position in the breast reconstruction market, the company pursues organic and inorganic strategies such as product approvals and acquisitions. Geographical Analysis in Detailed: The breast reconstruction market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America held the largest share of the market, followed by Europe. The rising incidences of breast cancer, increasing awareness of breast reconstruction, and FDA approvals for breast reconstruction products in this region are the major factors driving the growth of the breast reconstruction in North America. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=186501593
Lancets Market - Insights and In Depth Analysis of Industry Segments and Key Players
According to the new market research report ‘Lancets Market by Type (Safety Lancets (Push button, Pressure Activated, Side Button), Personal Lancets), Application (Glucose Testing, Hemoglobin Testing), End User (Hospital, Clinic, Homecare), Region – Global Forecast to 2024′, published by MarketsandMarkets™, the lancing devices market is projected to grow at a CAGR of 12.4% during the forecast period to reach USD 1,442 million by 2024 from USD 804 million in 2019. Recent Developments; - In 2018, HTL-STREFA expanded its storage capacity in Leczyca by almost 50%, with an equivalent of 3,550 m2 additional storage space. - In 2018, HTL-STREFA was acquired by Investindustrial. This acquisition helped the companies partner for diabetes management, thus serving an extensive customer base. - In 2017, Owen Mumford opened its new facility in Malaysia to strengthen and accelerate the growth of the company in the Asia Pacific region. Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=86063487 The Factors such as the growing prevalence of diabetes and the high prevalence of infectious diseases are driving the growth of the Glucose Lancets Market during the forecast period. Safety Lancet is expected to be the most widely used type of the Lancets Market The safety lancets accounted for the largest market share in 2018. This is primarily be attributed to the advantages associated with safety lancets such as their ease of use, the capability to prevent needlestick injuries and cross-contamination, and painlessness of vein puncture. In line with this, According to PharmaJet, in the US, around 600,000 to 800,000 needlestick injuries are reported every year. This is expected to increase the demand of safety lancets. Glucose testing segment is expected to account for the largest share of the Lancets Market application The glucose testing segment accounted for the largest share of the Lancing Devices Market, by application, in 2018. This is primarily due to the increasing prevalence of diabetes, and the need for its prevention and management. For instance, according to the International Diabetes Federation (IDF), in 2017, there were almost 425 million people suffering from diabetes worldwide, and this figure is expected to increase to 629 million by 2045. The growing prevalence of diabetes has resulted in the increased adoption of lancets to effectively handle the growing patient pool. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=86063487 Asia Pacific to dominate the Lancets Market during the forecast period In 2018, North America dominated the Lancing Devices Market, followed by Europe. Increasing prevalence of diabetes and favorable reimbursement scenario in the region are the factors propelling the growth of the market in the region. The Asia Pacific region is projected to register the highest growth rate in the global Lancet and Lancing Devices Market during the forecast period. This is primarily attributed to the rapid economic growth, rising awareness about diabetes treatment, rising geriatric population in China and India, and Japan’s growing healthcare industry. Prominent players in the Lancets Market are Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Own Mumford (UK), HTL-STREFA S.A (Poland), ARKRAY (Japan), Sarstedt (Germany), and SteriLance Medical (Suzhou) (China). Roche Diagnostics (Switzerland) is the diagnostics division of F. Hoffmann-La Roche AG. The company develops and manufactures equipment and reagents used for research and medical diagnostic applications. Roche operates through four business segments, namely, Centralized and Point of Care Solutions, Diabetes Care, Molecular Diagnostics, and Tissue Diagnostics. The company offers lancets to various end users including physicians, hospitals, clinics, academic institutes, and for personal use through its Diabetes Care segment. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=86063487